Webinar | Women’s Nutrition: Nourishing Womanhood From Pregnancy To Menopause
11 September | 12 PM ET: Register Now

Amped PCR

Reagent manufacturers and inventors of PurifAI
2022
1-10
1-10
Cardiff, Cardiff, United Kingdom
  • Artificial Intelligence (AI)
  • Biotechnology
  • Machine Learning
  • Machinery Manufacturing
  • Manufacturing

Investment Funding

Last Funding Stage

Seed

Total Funding Amount

$912.0K

Last Funding Amount

$535.0K

Last Funding Date

16-12-2024

Startup Stage

Seed

Lead Investors

Development Bank of Wales

Revenue

Less than $1M

People

Founders

About

Amped PCR are reagent manufacturers and developing PurifAI – a platform for detecting pathogens and AMR in real time replacing slow, culture-based lab tests with qPCR, sequencing, and cloud analytics. This enables rapid, scalable surveillance across applied markets such as Agri-Food, Environmental, and Veterinary.

Something missing or incorrect on this page? Help us enrich this information